Dr. Jennifer M. Suga
Claim this profileKaiser Permanente-Oakland
Expert in Lung Cancer
Expert in Non-Small Cell Lung Cancer
34 reported clinical trials
98 drugs studied
Area of expertise
1Lung Cancer
Global LeaderStage IV
Stage III
Stage II
2Non-Small Cell Lung Cancer
Global LeaderStage IV
Stage III
Stage II
Affiliated Hospitals
Clinical Trials Jennifer M. Suga is currently running
Chemotherapy + Hormone Therapy
for Breast Cancer
This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Recruiting2 awards Phase 319 criteria
Trastuzumab Emtansine
for Salivary Gland Cancer
This phase II trial tests whether ado-trastuzumab emtansine works to shrink tumors in patients with HER2-positive salivary gland cancer that has come back (recurrent), spread to other places in the body (metastatic), or cannot be removed by surgery (unresectable). Trastuzumab emtansine is a monoclonal antibody, called trastuzumab, linked to a chemotherapy drug called emtansine. Trastuzumab attaches to HER2 positive cancer cells in a targeted way and delivers emtansine to kill them. Trastuzumab emtansine may work better compared to usual treatment of chemotherapy with docetaxel and trastuzumab in treating patients with salivary gland cancer.
Recruiting1 award Phase 2
More about Jennifer M. Suga
Clinical Trial Related1 year of experience running clinical trials · Led 34 trials as a Principal Investigator · 14 Active Clinical TrialsTreatments Jennifer M. Suga has experience with
- Pembrolizumab
- Carboplatin
- Paclitaxel
- Pemetrexed
- Tucatinib
- Placebo
Breakdown of trials Jennifer M. Suga has run
Lung Cancer
Non-Small Cell Lung Cancer
Cancer
Breast Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Jennifer M. Suga specialize in?
Jennifer M. Suga focuses on Lung Cancer and Non-Small Cell Lung Cancer. In particular, much of their work with Lung Cancer has involved Stage IV patients, or patients who are Stage III.
Is Jennifer M. Suga currently recruiting for clinical trials?
Yes, Jennifer M. Suga is currently recruiting for 14 clinical trials in Oakland California. If you're interested in participating, you should apply.
Are there any treatments that Jennifer M. Suga has studied deeply?
Yes, Jennifer M. Suga has studied treatments such as Pembrolizumab, Carboplatin, Paclitaxel.
What is the best way to schedule an appointment with Jennifer M. Suga?
Apply for one of the trials that Jennifer M. Suga is conducting.
What is the office address of Jennifer M. Suga?
The office of Jennifer M. Suga is located at: Kaiser Permanente-Oakland, Oakland, California 94611 United States. This is the address for their practice at the Kaiser Permanente-Oakland.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.